ORAMED PHARMACEUTICALS INC. (ORMP)
Nasdaq · Pharmaceutical Preparations · Inc. DE
What they're doing
Not enough recent activity to summarise.
Signals, last 12 months
- Material 8-K filingFiled 8-K disclosing material agreement, acquisition or disposition of assets
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing director or officer change
- Material 8-K filingFiled 8-K disclosing material agreement
- Material 8-K filingFiled 8-K disclosing material agreement
Insider transactions
| Date | Insider | Role | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-02 | Hexter Joshua | officer | M | 50,000 | 3.69 | $184,500 |
| 2026-07-01 | Hexter Joshua | officer | S | 137,000 | 4.46 | $611,431 |
| 2026-07-01 | Gabay Avraham | officer | S | 73,360 | 4.51 | $330,744 |
| 2026-03-30 | KIDRON NADAV | director | F | 44,818 | 3.31 | $148,348 |
| 2026-03-30 | Kidron Miriam | director | F | 435,084 | 3.31 | $1,440,128 |
| 2026-03-30 | KIDRON NADAV | director | F | 44,818 | 3.31 | $148,348 |
| 2026-03-30 | Kidron Miriam | director | F | 435,084 | 3.31 | $1,440,128 |
| 2026-03-17 | Kidron Miriam | director | A | 119,558 | 0 | $0 |
| 2026-03-17 | KIDRON NADAV | director | A | 167,005 | 0 | $0 |
| 2026-03-17 | Hexter Joshua | officer | A | 95,889 | 0 | $0 |
| 2026-03-17 | Gabay Avraham | officer | A | 95,889 | 0 | $0 |
| 2026-03-17 | Kidron Miriam | director | A | 119,558 | 0 | $0 |
| 2026-03-17 | KIDRON NADAV | director | A | 167,005 | 0 | $0 |
| 2026-03-17 | Hexter Joshua | officer | A | 95,889 | 0 | $0 |
| 2026-03-17 | Gabay Avraham | officer | A | 95,889 | 0 | $0 |
| 2026-03-12 | KIDRON NADAV | director | G | 100,000 | 0 | $0 |
| 2026-03-12 | KIDRON NADAV | director | G | 100,000 | 0 | $0 |
| 2026-01-22 | KIDRON NADAV | director | M | 109,000 | 0 | $0 |
| 2026-01-22 | Kidron Miriam | director | M | 19,000 | 0 | $0 |
| 2026-01-22 | Hexter Joshua | officer | M | 19,000 | 0 | $0 |
| 2026-01-22 | Gabay Avraham | officer | M | 19,000 | 0 | $0 |
| 2026-01-22 | Hexter Joshua | officer | M | 19,000 | 0 | $0 |
| 2026-01-22 | Kidron Miriam | director | M | 19,000 | 0 | $0 |
| 2026-01-22 | Gabay Avraham | officer | M | 19,000 | 0 | $0 |
| 2026-01-22 | KIDRON NADAV | director | M | 109,000 | 0 | $0 |
| 2026-01-14 | Kidron Miriam | director | G | 86,166 | 0 | $0 |
| 2026-01-14 | Kidron Miriam | director | G | 86,166 | 0 | $0 |
| 2025-12-31 | Reznick Yehuda | director | A | 6,250 | — | — |
| 2025-12-31 | Reznick Yehuda | director | A | 30,000 | — | — |
| 2025-12-31 | KIDRON NADAV | director | A | 327,000 | 0 | $0 |
| 2025-12-31 | KIDRON NADAV | director | A | 232,640 | 0 | $0 |
| 2025-12-31 | Kidron Miriam | director | A | 121,331 | 0 | $0 |
| 2025-12-31 | Kidron Miriam | director | A | 115,000 | 0 | $0 |
| 2025-12-31 | Hexter Joshua | officer | A | 97,328 | 0 | $0 |
| 2025-12-31 | Hexter Joshua | officer | A | 115,000 | 0 | $0 |
| 2025-12-31 | Shapiro Benjamin | director | A | 30,000 | — | — |
| 2025-12-31 | Shapiro Benjamin | director | A | 3,500 | — | — |
| 2025-12-31 | Mayer Arie | director | A | 30,000 | — | — |
| 2025-12-31 | Mayer Arie | director | A | 4,900 | — | — |
| 2025-12-31 | Aghion Daniel | director | A | 6,250 | — | — |
| 2025-12-31 | Aghion Daniel | director | A | 30,000 | — | — |
| 2025-12-31 | Gabay Avraham | officer | A | 115,000 | 0 | $0 |
| 2025-12-31 | Gabay Avraham | officer | A | 81,216 | 0 | $0 |
| 2025-12-31 | Reznick Yehuda | director | A | 30,000 | — | — |
| 2025-12-31 | Reznick Yehuda | director | A | 6,250 | — | — |
| 2025-12-31 | KIDRON NADAV | director | A | 232,640 | 0 | $0 |
| 2025-12-31 | KIDRON NADAV | director | A | 327,000 | 0 | $0 |
| 2025-12-31 | Kidron Miriam | director | A | 121,331 | 0 | $0 |
| 2025-12-31 | Kidron Miriam | director | A | 115,000 | 0 | $0 |
| 2025-12-31 | Hexter Joshua | officer | A | 97,328 | 0 | $0 |
Federal contracts
No federal contract actions on record for this recipient mapping.
Lobbying
No federal lobbying filings on record for this client mapping.
Public attention
7-day average 6 views/day vs 90-day median 5.
Recent filings
- 2026-09-17 8-K
- 2026-08-14 SCHEDULE 13G/A
- 2026-08-10 10-Q
- 2026-08-03 ARS
- 2026-08-03 DEFA14A
- 2026-08-03 DEF 14A
- 2026-07-02 4
- 2026-07-02 4
- 2026-07-01 144
- 2026-07-01 144
- 2026-06-30 8-K
- 2026-06-29 SCHEDULE 13G/A
- 2026-05-19 10-Q
- 2026-05-15 NT 10-Q
- 2026-05-15 SCHEDULE 13G
- 2026-05-14 3
- 2026-05-14 SCHEDULE 13D
- 2026-03-31 8-K
- 2026-03-31 4
- 2026-03-31 4